34866927|t|Toll-Like Receptor 4 Polymorphisms (896A/G and 1196C/T) as an Indicator of COVID-19 Severity in a Convenience Sample of Egyptian Patients.
34866927|a|BACKGROUND: The clinical spectrum of COVID-19 is extremely variable. Thus, it is likely that the heterogeneity in the genetic make-up of the host may contribute to disease severity. Toll-like receptor (TLR)-4 plays a vital role in the innate immune response to SARS-CoV-2 infection. The susceptibility of humans to severe COVID-19 concerning TLR-4 single nucleotide polymorphisms (SNPs) has not been well examined. OBJECTIVE: The goal of this research was to investigate the association between TLR-4 (Asp299Gly and Thr399Ile) SNPs and COVID-19 severity and progression as well as the cytokine storm in Egyptian patients. METHODS: We genotyped 300 adult COVID-19 Egyptian patients for TLR-4 (Asp299Gly and Thr399Ile) SNPs using PCR-restriction fragment length polymorphism (PCR-RFLP). We also measured interleukin (IL)-6 levels by enzyme-linked immunosorbent assay (ELISA) as an indicator of the cytokine storm. RESULTS: The minor 299Gly (G) and 399Ile (T) alleles were associated with a significant (P < 0.001) positive risk of severe COVID-19 (OR = 3.14; 95% CI = 2.02-4.88 and OR = 2.75; 95% CI = 1.66-4.57), their frequency in the severe group were 71.8% (84/150) and 70.7% (58/150), respectively. We detected significant differences between TLR-4 (Asp299Gly, Thr399Ile) genotypes with regard to serum levels of IL-6. Levels of IL-6 increased significantly with the presence of the mutant 299Gly (G) and 399Ile (T) alleles to reach the highest levels in the Gly299Gly (GG) and the Ile399Ile (TT) genotypes (170 pg/mL (145-208.25) and 112 pg/mL (24-284.75), respectively). CONCLUSION: The TLR-4 (Asp299Gly and Thr399Ile) minor alleles 299Gly (G) and 399Ile (T) are associated with COVID-19 severity, mortality, and the cytokine storm.
34866927	0	20	Toll-Like Receptor 4	Gene	7099
34866927	36	42	896A/G	DNAMutation	tmVar:c|SUB|A|896|G;HGVS:c.896A>G;VariantGroup:0;CorrespondingGene:7099;RS#:4986790;CorrespondingSpecies:9606;CA#:118404
34866927	47	54	1196C/T	DNAMutation	tmVar:c|SUB|C|1196|T;HGVS:c.1196C>T;VariantGroup:1;CorrespondingGene:7099;RS#:4986791;CorrespondingSpecies:9606;CA#:118406
34866927	75	83	COVID-19	Disease	MESH:D000086382
34866927	129	137	Patients	Species	9606
34866927	176	184	COVID-19	Disease	MESH:D000086382
34866927	321	347	Toll-like receptor (TLR)-4	Gene	7099
34866927	400	420	SARS-CoV-2 infection	Disease	MESH:D000086382
34866927	444	450	humans	Species	9606
34866927	461	469	COVID-19	Disease	MESH:D000086382
34866927	481	486	TLR-4	Gene	7099
34866927	634	639	TLR-4	Gene	7099
34866927	641	650	Asp299Gly	ProteinMutation	tmVar:p|SUB|D|299|G;HGVS:p.D299G;VariantGroup:0;CorrespondingGene:7099;RS#:4986790;CorrespondingSpecies:9606;CA#:118404
34866927	655	664	Thr399Ile	ProteinMutation	tmVar:p|SUB|T|399|I;HGVS:p.T399I;VariantGroup:1;CorrespondingGene:7099;RS#:4986791;CorrespondingSpecies:9606;CA#:118406
34866927	675	683	COVID-19	Disease	MESH:D000086382
34866927	751	759	patients	Species	9606
34866927	793	801	COVID-19	Disease	MESH:D000086382
34866927	811	819	patients	Species	9606
34866927	824	829	TLR-4	Gene	7099
34866927	831	840	Asp299Gly	ProteinMutation	tmVar:p|SUB|D|299|G;HGVS:p.D299G;VariantGroup:0;CorrespondingGene:7099;RS#:4986790;CorrespondingSpecies:9606;CA#:118404
34866927	845	854	Thr399Ile	ProteinMutation	tmVar:p|SUB|T|399|I;HGVS:p.T399I;VariantGroup:1;CorrespondingGene:7099;RS#:4986791;CorrespondingSpecies:9606;CA#:118406
34866927	941	959	interleukin (IL)-6	Gene	3569
34866927	1070	1080	299Gly (G)	ProteinMutation	tmVar:p|Allele|G|299;VariantGroup:0;CorrespondingGene:7099;RS#:4986790;CorrespondingSpecies:9606
34866927	1085	1095	399Ile (T)	ProteinMutation	tmVar:p|SUB|I|399|T;HGVS:p.I399T;VariantGroup:1;CorrespondingGene:7099;RS#:4986791;CorrespondingSpecies:9606;CA#:118406
34866927	1175	1183	COVID-19	Disease	MESH:D000086382
34866927	1385	1390	TLR-4	Gene	7099
34866927	1392	1401	Asp299Gly	ProteinMutation	tmVar:p|SUB|D|299|G;HGVS:p.D299G;VariantGroup:0;CorrespondingGene:7099;RS#:4986790;CorrespondingSpecies:9606;CA#:118404
34866927	1403	1412	Thr399Ile	ProteinMutation	tmVar:p|SUB|T|399|I;HGVS:p.T399I;VariantGroup:1;CorrespondingGene:7099;RS#:4986791;CorrespondingSpecies:9606;CA#:118406
34866927	1455	1459	IL-6	Gene	3569
34866927	1471	1475	IL-6	Gene	3569
34866927	1532	1542	299Gly (G)	ProteinMutation	tmVar:p|Allele|G|299;VariantGroup:0;CorrespondingGene:7099;RS#:4986790;CorrespondingSpecies:9606
34866927	1547	1557	399Ile (T)	ProteinMutation	tmVar:p|SUB|I|399|T;HGVS:p.I399T;VariantGroup:1;CorrespondingGene:7099;RS#:4986791;CorrespondingSpecies:9606;CA#:118406
34866927	1601	1610	Gly299Gly	ProteinMutation	tmVar:p|SUB|G|299|G;HGVS:p.G299G;VariantGroup:0;CorrespondingGene:7099;RS#:4986790;CorrespondingSpecies:9606
34866927	1624	1633	Ile399Ile	ProteinMutation	tmVar:p|SUB|I|399|I;HGVS:p.I399I;VariantGroup:1;CorrespondingGene:7099;RS#:4986791;CorrespondingSpecies:9606
34866927	1731	1736	TLR-4	Gene	7099
34866927	1738	1747	Asp299Gly	ProteinMutation	tmVar:p|SUB|D|299|G;HGVS:p.D299G;VariantGroup:0;CorrespondingGene:7099;RS#:4986790;CorrespondingSpecies:9606;CA#:118404
34866927	1752	1761	Thr399Ile	ProteinMutation	tmVar:p|SUB|T|399|I;HGVS:p.T399I;VariantGroup:1;CorrespondingGene:7099;RS#:4986791;CorrespondingSpecies:9606;CA#:118406
34866927	1777	1787	299Gly (G)	ProteinMutation	tmVar:p|Allele|G|299;VariantGroup:0;CorrespondingGene:7099;RS#:4986790;CorrespondingSpecies:9606
34866927	1792	1802	399Ile (T)	ProteinMutation	tmVar:p|SUB|I|399|T;HGVS:p.I399T;VariantGroup:1;CorrespondingGene:7099;RS#:4986791;CorrespondingSpecies:9606;CA#:118406
34866927	1823	1831	COVID-19	Disease	MESH:D000086382
34866927	Association	MESH:D000086382	RS#:4986790;HGVS:p.D299G;CorrespondingGene:7099
34866927	Positive_Correlation	MESH:D000086382	RS#:4986790;HGVS:c.896A>G;CorrespondingGene:7099
34866927	Positive_Correlation	MESH:D000086382	RS#:4986791;HGVS:c.1196C>T;CorrespondingGene:7099
34866927	Association	RS#:4986791;HGVS:c.1196C>T;CorrespondingGene:7099	MESH:D000086382
34866927	Positive_Correlation	MESH:D000086382	RS#:4986790;HGVS:p.G299G;CorrespondingGene:7099
34866927	Association	RS#:4986790;HGVS:c.896A>G;CorrespondingGene:7099	MESH:D000086382
34866927	Positive_Correlation	MESH:D000086382	RS#:4986791;HGVS:p.I399I;CorrespondingGene:7099
34866927	Association	RS#:4986790;HGVS:c.896A>G;CorrespondingGene:7099	RS#:4986791;HGVS:c.1196C>T;CorrespondingGene:7099
34866927	Association	MESH:D000086382	RS#:4986791;HGVS:p.T399I;CorrespondingGene:7099
34866927	Positive_Correlation	MESH:D000086382	RS#:4986790;CorrespondingGene:7099
34866927	Association	3569	7099
34866927	Association	MESH:D000086382	7099
34866927	Positive_Correlation	MESH:D000086382	RS#:4986791;HGVS:p.I399T;CorrespondingGene:7099
34866927	Association	MESH:D000086382	7099

